Stock Markets

Abbott adds 3% after earnings beat

© Reuters. Abbott (ABT) adds 3% after earnings beat
Add to/Remove from Watchlist

Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio


By Senad Karaahmetovic

Abbott (NYSE:ABT) shares are trading higher in pre-market Wednesday after the medical device company posted better-than-expected Q1 results.

Abbott said it earned $1.03 per share on sales of $9.75 billion, beating the consensus for earnings of $0.99 per share on revenue of $9.66B. Overall, sales fell 18% year-over-year as diagnostics revenue plunged 49% to $2.69B.

“Our first-quarter results reflect a very strong start to the year,” said Robert B. Ford, chairman and chief executive officer, Abbott. “Growth in our underlying base businesses accelerated, including particularly strong results in Medical Devices, Established Pharmaceuticals and Nutrition.”

For FY23, the company projects EPS at $4.40 (up or down 10 cents). Abbott also sees “at least high single-digit FY organic sales growth.”

Ukraine’s Marchenko says G7 support crucial for ‘longer’ war with Russia

Previous article

Interactive Strength Announces Downsized 1.5M Share IPO at $6-$8/sh

Next article
As a seasoned financier, I have a keen eye for identifying profitable investment opportunities and creating strategic financial plans. My expertise in risk management and financial analysis has enabled me to deliver exceptional returns for my clients and stakeholders.

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *